ECOSYSTEM

SABC-HLP Ecosystem >

Technology Transfer

Global Partnerships & Technology Transfer

SABC-HLP Network provides a strategic gateway between East and West, supporting the development, transfer, and clinical implementation of advanced stem cell and gene therapy technologies under international standards.

iPS Stem cell- Meaningful framework for Organ Regeneration & Repair strategies

Induced Pluripotent Stem Cell (iPSC)

SABC collaborates with leading international partners advancing clinical-stage iPSC-derived therapies for liver disorders, neurological diseases, and graft-versus-host disease (GvHD). These innovative approaches aim to promote tissue repair and regeneration directly within the body, expanding the future of regenerative medicine.

Extracellular Vesicles - Ideal biomaterials for regenerative nanomedicine applications

Owing to their natural targeting capability, low immunogenicity, biological stability, and ability to cross physiological barriers, EVs have emerged as promising next-generation therapeutics and diagnostic tools.

Through its open GMP-cGMP manufacturing platform, HLP supports the research, development, and scalable production of high-quality extracellular vesicle and exosome-based products for translational and clinical applications.

Photo: Robin L. Webb et al, Translational Stroke Research , 2018

Stem cell-Gene Editing : Cutting -Edge Cancer Figting Tools

Stem cell and gene-engineered immunotherapies represent a breakthrough in cancer treatment, harnessing the body's immune system to recognize and eliminate malignant cells. SABC aims to update next-generation cell and gene therapies, delivering innovative treatment solutions with the potential for durable, long-term cancer control and eradication.